Lymphoma Action

NICE recommends Axicabtagene ciloleucel for DLBCL

Standard post

… ciloleucel as an option for treating relapsed or refractory diffuse large B-cell lymphoma (DLBCL) or primary … February 2023 … New treatment available for relapsed or refractory diffuse large B-cell lymphoma or primary …

Get involved – NICE consultation on duvelisib for relapsed or refractory CLL/SLL

Standard post

… involved – NICE consultation on duvelisib for relapsed or refractory CLL/SLL …

New antibody therapy shows potential for people with relapsed or refractory B-cell non-Hodgkin lymphomas

Standard post

… results. Overall, 68% of people with relapsed or refractory DLBCL and 90% of people with relapsed or refractory follicular lymphoma had a partial or complete … therapy shows potential for people with relapsed or refractory B-cell non-Hodgkin lymphomas …

Pembrolizumab for classical Hodgkin lymphoma

Standard post

… Cancer Drugs Fund as an option for treating relapsed or refractory classical Hodgkin lymphoma in adults who have had … Although it is not recommended for treating relapsed or refractory classical Hodgkin lymphoma in adults who have had … recommend pembrolizumab for people with relapsed or refractory Hodgkin lymphoma who have had brentuximab vedotin …

New treatment for skin lymphoma not to be available on the NHS in England and Wales

Standard post

… mogamulizumab for the treatment of relapsed or refractory mycosis fungoides or Sézary syndrome. … New …

New treatment for skin lymphoma available on the NHS in England and Wales

Standard post

… recommended mogamulizumab for the treatment of relapsed or refractory mycosis fungoides or Sézary syndrome … New …

Early results of avelumab in Hodgkin lymphoma

Standard post

… has shown early evidence of activity against relapsed or refractory Hodgkin lymphoma. … Early results of avelumab in …

CCS1477-02: a phase 1/2a study of CCS1477 in blood cancers, including relapsed or refractory non-Hodgkin lymphoma

Trial

… that have come back ( relapsed ) or has not responded ( refractory ) after previous treatment. The trial aims to find … side effects. Who can enter Adults with relapsed or refractory NHL which has been treated with one other … study of CCS1477 in blood cancers, including relapsed or refractory non-Hodgkin lymphoma …

CPI-0209: A study of CPI-0209 in relapsed or refractory diffuse large B-cell and peripheral T-cell lymphomas

Trial

… T-cell lymphoma (PTCL) which has failed to respond to (refractory) or returned after (relapsed) one systemic … NCT04104776 … CPI-0209: A study of CPI-0209 in relapsed or refractory diffuse large B-cell and peripheral T-cell …

BRUIN-MCL-321: A phase 3 trial of a targeted treatment called pirtobrutinib in people with relapsed or refractory mantle cell lymphoma

Trial

… existing drugs of the same type in people with relapsed or refractory mantle cell lymphoma . People who take part in … treatment called pirtobrutinib in people with relapsed or refractory mantle cell lymphoma …